Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Releases New SNP Assay; Eliminates Need for Sample Transfer

NEW YORK, Feb 27 – Sequenom has released a new version of its MassEXTEND assay that eliminates sample transfers, the company said Tuesday. 

The new product, called the homogeneous MassEXTEND, or hME, assay, is part of a larger automated system for analyzing SNPs called MassARRAY that includes a mass spectrometer, dispensing unit, and software interface.

“The hME assay improves on this product by integrating all of the reactions on a single surface without compromising accuracy,” Charlie Rodi, Sequenom vice president of molecular biology and manager of corporate research, said in a statement.

The hME assay is also designed to work with Sequenom’s 384 SpectroCHIP, a two by three centimeter silicon chip containing 384 sites preloaded with a MALDI matrix. “This significantly decreases the sample volumes required, thereby reducing the consumption of materials and the cost per sample,” said Rodi.

On Monday, Sequenom and the Genomics Research Institute of the Novartis Research Foundation said they would collaborate on a SNP study of the mouse genome. As part of the deal, Novartis agreed to buy a MassARRAY system from Sequenom.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.